HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$1.57
Day range
$1.52 - $1.65
Year range
$1.28 - $5.50
Market cap
135.55M USD
Avg Volume
332.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 771.00K | 678.79% |
Operating expense | 8.31M | 0.94% |
Net income | -31.21M | 6.26% |
Net profit margin | -4.05K | 87.96% |
Earnings per share | -0.38 | 22.54% |
EBITDA | -31.29M | -13.29% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 196.40M | 25.58% |
Total assets | 416.45M | -0.17% |
Total liabilities | 194.34M | 14.60% |
Total equity | 222.10M | — |
Shares outstanding | 84.72M | — |
Price to book | 0.60 | — |
Return on assets | -22.72% | — |
Return on capital | -34.56% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -31.21M | 6.26% |
Cash from operations | -27.33M | -41.98% |
Cash from investing | -33.86M | -585.57% |
Cash from financing | 56.70M | 660.41% |
Net change in cash | -4.50M | 79.91% |
Free cash flow | -12.65M | 23.61% |
About
Founded
2018
Headquarters
Website
Employees
152